NewGenIvf Group Limited Class A Ordinary Shares (NIVF) - Cash Flow Conversion Efficiency
Based on the latest financial reports, NewGenIvf Group Limited Class A Ordinary Shares (NIVF) has a cash flow conversion efficiency ratio of 4.973x as of March 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-6.35 Million) by net assets ($-1.28 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See debt-free asset ratio of NewGenIvf Group Limited Class A Ordinary to measure how much of total assets are equity-financed.
NewGenIvf Group Limited Class A Ordinary Shares - Cash Flow Conversion Efficiency Trend (2021–2024)
This chart illustrates how NewGenIvf Group Limited Class A Ordinary Shares's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check NIVF cash flow quality score to evaluate the quality of earnings relative to operating cash generation.
NewGenIvf Group Limited Class A Ordinary Shares Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of NewGenIvf Group Limited Class A Ordinary Shares ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
PDG Realty S.A. Empreendimentos e Participações
SA:PDGR3
|
0.000x |
|
Asian Television Network International Ltd
V:SAT
|
-0.121x |
|
Deutsche Effecten- und Wechsel-Beteiligungsgesellschaft AG
XETRA:EFF
|
0.000x |
|
Cyber Security 1 AB
ST:CYB1
|
0.681x |
|
Biomotion Sciences Ordinary Shares
NASDAQ:SLXN
|
-12.529x |
|
ENGAGE XR HLDGS EO-001
F:6VR
|
N/A |
|
ODINWELL AB
F:0AF
|
N/A |
|
Europejskie Centrum Odszkodowań SA
WAR:EUC
|
0.002x |
Annual Cash Flow Conversion Efficiency for NewGenIvf Group Limited Class A Ordinary Shares (2021–2024)
The table below shows the annual cash flow conversion efficiency of NewGenIvf Group Limited Class A Ordinary Shares from 2021 to 2024. For the full company profile with market capitalisation and key ratios, see NewGenIvf Group Limited Class A Ordinary market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $-1.48 Million | $-8.26 Million | 5.577x | +10245.75% |
| 2023-12-31 | $15.60 Million | $-857.36K | -0.055x | -612.49% |
| 2022-12-31 | $68.32 Million | $-527.12K | -0.008x | +99.51% |
| 2021-12-31 | $-914.91K | $1.43 Million | -1.566x | -- |
About NewGenIvf Group Limited Class A Ordinary Shares
NewGenIvf Group Limited, an investment holding company, provides an assisted reproductive service that helps couples and individuals for fertility treatments in Thailand, Cambodia, Hong Kong, and Kyrgyzstan. The company's fertility treatment solutions include in vitro fertilization (IVF), ICSI, embryo culture, hormonal blood tests, infectious diseases tests, chromosome screening, hysteroscopy, sp… Read more